Deepak Nitrite Ltd (DEEPAKNTR) Q1 FY27 Results Analysis: PAT Surges 207%, Both Segments Fire
Deepak Nitrite Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 2,577.60 Cr (+36.39% YoY) and PAT growth of +207.36% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 04, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 2,577.60 Cr (+36.39% YoY) |
| PAT (Q1) | Rs. 345.01 Cr (+207.36% YoY) |
| EBITDA margin | 20.96% (+1093 bps YoY) |
| EPS (Q1) | Rs. 25.30 (+207.41% YoY) |
| Market cap | Rs. 23,428.23 Cr |
| CMP | Rs. 1,717.70 |
Quarter Snapshot
DEEPAKNTR delivered record revenue and EBITDA margin, with both segments firing on all cylinders. Strong domestic demand and Chinese supply-side tailwinds drove 36% revenue growth and 207% PAT growth. However, rising finance costs and depreciation from the capex cycle, along with the risk of margin compression once the feedstock inventory is consumed, temper the outlook.
Key Investment Insights
Key Positives
- Revenue at Rs.2,577.60 Cr is the highest quarterly print, growing 36.4% YoY.
- EBITDA margin expanded to 20.96% from 10.03% YoY (1,093 bps improvement).
- PAT grew 207.4% YoY to Rs.345.01 Cr.
- Both segments delivered record EBIT margins: Phenolics 23.54% and Advanced Intermediates 8.33%.
- Management guidance of Q1 > Q4 was met on revenue, EBITDA, and PAT.
- Chinese supply-side tailwinds from the Hazardous Chemicals Safety Law and global plant shutdowns are structurally benefiting the business.
Risk Factors
- Finance costs increased 181.8% YoY to Rs.22.91 Cr due to higher debt for the capex cycle.
- Depreciation rose 24.2% YoY to Rs.63.66 Cr as new assets were capitalised.
- Other expenses grew 40.9% YoY, faster than revenue, partly due to freight and project-related costs.
- The feedstock inventory buffer that boosted Phenolics margins in Q1 will not repeat in subsequent quarters, raising the risk of margin compression.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.